Papers by Richard Gessner
Journal of Medicinal Chemistry, 2011
A novel class of antimalarial pyrido[1,2-a]benzimidazoles were synthesized and evaluated for anti... more A novel class of antimalarial pyrido[1,2-a]benzimidazoles were synthesized and evaluated for antiplasmodial activity and cytotoxicity following hits identified from screening commercially available compound collections. The most active of these, TDR86919 (4c), showed improved in vitro activity vs the drug-resistant K1 strain of Plasmodium falciparum relative to chloroquine (IC(50) = 0.047 μM v 0.17 μM); potency was retained against a range of drug-sensitive and drug-resistant strains, with negligible cytotoxicity against the mammalian (L-6) cell line (selectivity index of >600). 4c and several close analogues (as HCl or mesylate salts) showed significant efficacy in P. berghei infected mice following both intraperitoneal (ip) and oral (po) administration, with >90% inhibition of parasitemia, accompanied by an increase in the mean survival time (MSD). The pyrido[1,2-a]benzimidazoles appeared to be relatively slow acting in vivo compared to chloroquine, and metabolic stability of the alkylamino side chain was identified as a key issue in influencing in vivo activity.
Journal of medicinal chemistry, Jan 17, 2017
A BioFocus DPI SoftFocus library of ~35,000 compounds was screened against Mycobacterium tubercul... more A BioFocus DPI SoftFocus library of ~35,000 compounds was screened against Mycobacterium tuberculosis (Mtb) in order to identify novel hits with anti-tubercular activity. The hits were evaluated in biology triage assays to exclude compounds suggested to function via frequently encountered promiscuous mechanisms of action including inhibition of the QcrB subunit of the cytochrome bc1 complex, disruption of cell-wall homeostasis, and DNA damage. Among the hits which passed this screening cascade, a 6-dialkylaminopyrimidine carboxamide series was prioritized for hit to lead optimization. Compounds from this series were active against clinical Mtb strains while no cross-resistance to conventional anti-tuberculosis drugs was observed. This suggested a novel mechanism of action, which was confirmed by chemoproteomic analysis leading to the identification of BCG_3193 and BCG_3827 as putative targets of the series with unknown function. Initial structure-activity relationship studies have r...
Synlett, 2009
... A New and Simple Synthesis of Sulfonyl Ureas from Sulfonamides and N-Alkyl-1,2,4-dithiazolidi... more ... A New and Simple Synthesis of Sulfonyl Ureas from Sulfonamides and N-Alkyl-1,2,4-dithiazolidine-3,5-diones. Richard K. Gessner a , Kelly Chibale* a,b. ... 5 Wood ME, Cane-Honeysett DJ, Dowle MD, Coles SJ, Hursthouse MB,Org. Biomol. Chem. 2003, 1: 3015. ...
Bioorganic & Medicinal Chemistry, 2016
Journal of medicinal chemistry, Jan 9, 2015
High throughput screening of a library of small polar molecules against Mycobacterium tuberculosi... more High throughput screening of a library of small polar molecules against Mycobacterium tuberculosis led to the identification of a phthalimide-containing ester hit compound (1), which was optimized for metabolic stability by replacing the ester moiety with a methyl oxadiazole bioisostere. A route utilizing polymer-supported reagents was designed and executed to explore structure activity relationships with respect to the N-benzyl substituent, leading to compounds with nanomolar activity. The frontrunner compound (5h) from these studies was well tolerated in mice. A M. tuberculosis cytochrome bd oxidase deletion mutant (∆cydKO) was hyper-susceptible to compounds from this series, and a strain carrying a single point mutation in qcrB, the gene encoding a subunit of the menaquinol cytochrome c oxidoreductase, was resistant to compounds in this series. In combination, these observations indicate that this novel class of anti-mycobacterial compounds inhibits the cytochrome bc1 complex, a ...
Bioorganic & medicinal chemistry, Jan 22, 2015
Whole-cell high-throughput screening of a diverse SoftFocus library against Mycobacterium tubercu... more Whole-cell high-throughput screening of a diverse SoftFocus library against Mycobacterium tuberculosis (Mtb) generated a novel aminopyrazolo[1,5-a]pyrimidine hit series. The synthesis and structure activity relationship studies identified compounds with potent antimycobacterial activity. The SAR of over 140 compounds shows that the 2-pyridylmethylamine moiety at the C-7 position of the pyrazolopyrimidine scaffold was important for Mtb activity, whereas the C-3 position offered a higher degree of flexibility. The series was also profiled for in vitro cytotoxicity and microsomal metabolic stability as well as physicochemical properties. Consequently liabilities to be addressed in a future lead optimization campaign have been identified.
ChemInform, 2010
A New and Simple Synthesis of Sulfonyl Ureas from Sulfonamides and N-Alkyl--1,2,4-dithiazolidine-... more A New and Simple Synthesis of Sulfonyl Ureas from Sulfonamides and N-Alkyl--1,2,4-dithiazolidine-3,5-diones. -N-Alkylation of 1,2,4-dithiazole-3,5-dione with functionalized alkyl bromides is easily achieved under mild conditions. The resulting products (III) react with aryl sulfinamides to give the pharmaceutically interesting target compounds (V). -(GESSNER, R. K.; CHIBALE*, K.; Synlett 2009Synlett , 17, 2839Synlett -2843 Dep. Chem., Univ. Cape Town, Rondebosch 7700, Cape Town, S. Afr.; Eng.) -Mais 09-082
Synlett, 2009
... A New and Simple Synthesis of Sulfonyl Ureas from Sulfonamides and N-Alkyl-1,2,4-dithiazolidi... more ... A New and Simple Synthesis of Sulfonyl Ureas from Sulfonamides and N-Alkyl-1,2,4-dithiazolidine-3,5-diones. Richard K. Gessner a , Kelly Chibale* a,b. ... 5 Wood ME, Cane-Honeysett DJ, Dowle MD, Coles SJ, Hursthouse MB,Org. Biomol. Chem. 2003, 1: 3015. ...
Journal of Medicinal Chemistry, 2011
Uploads
Papers by Richard Gessner